Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. GLPG
GLPG logo

GLPG

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GLPG News

Galapagos Launches New Subscription Rights Plan

4d agoNewsfilter

Galapagos Receives Transparency Notification from Bank of America

6d agoYahoo Finance

Galapagos Reports FY 2023 Financial Results with Significant Revenue Growth

Feb 24 2026seekingalpha

Galapagos Set to Announce Q4 Earnings on February 23

Feb 20 2026seekingalpha

Bank of America Exceeds 5% Voting Rights in Galapagos

Feb 16 2026Newsfilter

Vistra Corp Acquires Cogentrix Energy for Approximately $4.7 Billion

Jan 06 2026Benzinga

Microchip Technology Raises Q3 FY2026 Sales Guidance to $1.185 Billion

Jan 06 2026Benzinga

Galapagos GLPG3667 Achieves Significant Clinical Benefit in Dermatomyositis Study

Dec 18 2025Globenewswire

Galapagos GLPG3667 Achieves Significant Clinical Benefit in Dermatomyositis Study

Dec 18 2025Newsfilter

Galapagos Achieves Key Objective in Phase 3 Study for Rare Autoimmune Disease Treatment

Dec 18 2025SeekingAlpha

GLPG Surpasses Average Analyst Expectations

Dec 12 2025NASDAQ.COM

Galapagos Presents New GLPG5101 Data with 100% Response Rate in MCL Patients

Dec 08 2025Globenewswire

Galapagos Reports 96% CR Rate for GLPG5101 in MCL Patients at ASH 2025

Dec 08 2025Newsfilter

Bank of America Increases Galapagos Voting Rights to 5.26%

Nov 26 2025Newsfilter

GLPG Surpasses Average Analyst Price Target

Oct 29 2025NASDAQ.COM

Leerink Partners Raises Rating on Galapagos NV - Depositary Receipt (GLPG)

Oct 22 2025NASDAQ.COM